Syndex Bio

Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.

Health and bio

Syndex Bio raised $15.5M in a Seed round announced February 23, 2026, according to European Biotechnology Magazine.

Founders and team

• GS
  Geoff Smith Founder

  source: crunchbase.com

Raise history

1. February 23, 2026
   Seed · $15.5M
   Source: European Biotechnology Magazine

Related ai companies

• GGood Tape$600K · Oct 2, 2026
• OOptimizeGEO.ai$80M · Oct 1, 2026
• 11club AI$2.2M · Oct 1, 2026
• PPredictive AIOct 1, 2026
• JJAOPS$260M · Oct 1, 2026
• EestaieOct 1, 2026
• OOpensOct 1, 2026
• KKeepsake Family HistoryOct 1, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/syndex-bio.